Peer-reviewedCC BY 4.0Clinical Case Reports
A Case of Recurrent Gastric Cancer in Which Rheumatoid Arthritis and Sjögren's Syndrome Became Evident With Nivolumab
- 1Division of Digestive Surgery, Department of Surgery Kyoto Prefectural University of Medicine Kyoto Japan
- 2Iseikai International General Hospital Osaka Japan
Abstract
A 59‐year‐old man with recurrent gastric cancer began nivolumab as third‐line therapy and subsequently experienced joint pain and dry eyes. Symptoms worsened despite NSAIDs. He was diagnosed with rheumatoid arthritis and Sjögren's syndrome, associated with nivolumab, and was successfully treated with immunosuppressive and anti‐rheumatic medications.
Related
- Sleeve gastrectomy is associated with a higher incidence of rheumatoid arthritis and spondyloarthritis compared to gastric bypass
- The CALLY Index for Unresectable or Recurrent Gastric Cancer Treated With Nivolumab: A Multicenter Retrospective Study.
- Clinical outcomes of first-line nivolumab plus chemotherapy in patients aged ≥ 75 years with unresectable advanced or recurrent gastric cancer: a retrospective study.
- Case Report: Orbital and intracranial inflammatory syndrome in rheumatoid arthritis
- Limited Joint Mobility Syndrome Mimicking Rheumatoid Arthritis in a Patient with Type 2 Diabetes Mellitus: A Case Report
BibTeX
@article{takemoto2026case,
title = {{A Case of Recurrent Gastric Cancer in Which Rheumatoid Arthritis and Sjögren's Syndrome Became Evident With Nivolumab}},
author = {Haruhiko Takemoto and Keiji Nishibeppu and Takeshi Kubota and Hiroyuki Inoue and Kazuya Takabatake and Hirotaka Konishi and Hitoshi Fujiwara and Atsushi Shiozaki},
journal = {Clinical Case Reports},
year = {2026},
month = nov,
doi = {10.1002/ccr3.73855},
url = {https://doi.org/10.1002/ccr3.73855},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A Case of Recurrent Gastric Cancer in Which Rheumatoid Arthritis and Sjögren's Syndrome Became Evident With Nivolumab
AU - Haruhiko Takemoto
AU - Keiji Nishibeppu
AU - Takeshi Kubota
AU - Hiroyuki Inoue
AU - Kazuya Takabatake
AU - Hirotaka Konishi
AU - Hitoshi Fujiwara
AU - Atsushi Shiozaki
PY - 2026
DA - 2026/11/03
JO - Clinical Case Reports
DO - 10.1002/ccr3.73855
UR - https://doi.org/10.1002/ccr3.73855
AB - A 59‐year‐old man with recurrent gastric cancer began nivolumab as third‐line therapy and subsequently experienced joint pain and dry eyes. Symptoms worsened despite NSAIDs. He was diagnosed with rheumatoid arthritis and Sjögren's syndrome, associated with nivolumab, and was successfully treated with immunosuppressive and anti‐rheumatic medications.
SN - 2050-0904
ER -